P. Mccullough, E. Philbin, J. Spertus, S. Kaatz, and K. Sandberg, Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study, Journal of the American College of Cardiology, vol.39, issue.1, pp.60-69, 2002.
DOI : 10.1016/S0735-1097(01)01700-4

J. Cleland, K. Swedberg, F. Follath, M. Komajda, and A. Cohen-solal, The EuroHeart Failure survey programme???a survey on the quality of care among patients with heart failure in Europe Part 1: patient characteristics and diagnosis, European Heart Journal, vol.24, issue.5, pp.442-463, 2003.
DOI : 10.1016/S0195-668X(02)00823-0

P. Jourdain, G. Jondeau, F. Funck, P. Gueffet, L. Helloco et al., Plasma Brain Natriuretic Peptide-Guided Therapy to Improve Outcome in Heart Failure, Journal of the American College of Cardiology, vol.49, issue.16, pp.1733-1739, 2007.
DOI : 10.1016/j.jacc.2006.10.081

R. Ferrari, T. Bachetti, R. Confortini, C. Opasich, and O. Febo, Tumor Necrosis Factor Soluble Receptors in Patients With Various Degrees of Congestive Heart Failure, Circulation, vol.92, issue.6, pp.1479-1486, 1995.
DOI : 10.1161/01.CIR.92.6.1479

N. Nozaki, S. Yamaguchi, M. Shirakabe, H. Nakamura, and H. Tomoike, Soluble Tumor Necrosis Factor Receptors are Elevated in Relation to Severity of Congestive Heart Failure, Japanese Circulation Journal, vol.61, issue.8, pp.657-664, 1997.
DOI : 10.1253/jcj.61.657

M. Keith, A. Geranmayegan, M. Sole, R. Kurian, and A. Robinson, Increased Oxidative Stress in Patients With Congestive Heart Failure 11This study was supported by a grant jointly sponsored by the Medical Research Council of Canada, Ottawa and Bayer Pharmaceuticals, Etobicoke, Ontario, Canada., Journal of the American College of Cardiology, vol.31, issue.6, pp.1352-1356, 1998.
DOI : 10.1016/S0735-1097(98)00101-6

M. Rauchhaus, W. Doehner, D. Francis, C. Davos, and M. Kemp, Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure, Circulation, vol.102, issue.25, pp.3060-3067, 2000.
DOI : 10.1161/01.CIR.102.25.3060

A. Deswal, N. Petersen, A. Feldman, J. Young, and B. White, Cytokines and Cytokine Receptors in Advanced Heart Failure : An Analysis of the Cytokine Database from the Vesnarinone Trial (VEST), Circulation, vol.103, issue.16, pp.2055-2059, 2001.
DOI : 10.1161/01.CIR.103.16.2055

D. Mann, Inflammatory Mediators and the Failing Heart: Past, Present, and the Foreseeable Future, Circulation Research, vol.91, issue.11, pp.988-998, 2002.
DOI : 10.1161/01.RES.0000043825.01705.1B

M. Valgimigli, C. Ceconi, P. Malagutti, E. Merli, and O. Soukhomovskaia, Tumor Necrosis Factor-?? Receptor 1 Is a Major Predictor of Mortality and New-Onset Heart Failure in Patients With Acute Myocardial Infarction: The Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) Study, Circulation, vol.111, issue.7, pp.863-870, 2005.
DOI : 10.1161/01.CIR.0000155614.35441.69

D. Isaac, Biomarkers in heart failure management, Current Opinion in Cardiology, vol.23, issue.2, pp.127-133, 2008.
DOI : 10.1097/HCO.0b013e3282f43039

A. Maisel, J. Hollander, D. Guss, P. Mccullough, and R. Nowak, Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT), Journal of the American College of Cardiology, vol.44, issue.6, pp.1328-1333, 2004.
DOI : 10.1016/j.jacc.2004.06.015

D. Morrow, J. De-lemos, M. Blazing, M. Sabatine, and S. Murphy, Prognostic Value of Serial B-Type Natriuretic Peptide Testing During Follow-up of Patients With Unstable Coronary Artery Disease, JAMA, vol.294, issue.22, pp.2866-2871, 2005.
DOI : 10.1001/jama.294.22.2866

M. Nishii, T. Inomata, H. Takehana, T. Naruke, and T. Yanagisawa, Prognostic Utility of B-Type Natriuretic Peptide Assessment in Stable Low-Risk Outpatients With Nonischemic Cardiomyopathy After Decompensated Heart Failure, Journal of the American College of Cardiology, vol.51, issue.24, pp.2329-2335, 2008.
DOI : 10.1016/j.jacc.2007.11.085

R. Pfister, M. Scholz, K. Wielckens, E. Erdmann, and C. Schneider, Use of NT-proBNP in routine testing and comparison to BNP, European Journal of Heart Failure, vol.127, issue.3, pp.289-293, 2004.
DOI : 10.1016/j.ejheart.2003.12.012

W. Tang, G. Francis, D. Morrow, L. Newby, and C. Cannon, National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Utilization of Cardiac Biomarker Testing in Heart Failure, Clinical Biochemistry, vol.41, issue.4-5, pp.99-109, 2007.
DOI : 10.1016/j.clinbiochem.2007.07.002

P. Garvin, L. Nilsson, J. Carstensen, L. Jonasson, and M. Kristenson, Circulating Matrix Metalloproteinase-9 Is Associated with Cardiovascular Risk Factors in a Middle-Aged Normal Population, PLoS ONE, vol.37, issue.3, p.1774, 2008.
DOI : 10.1371/journal.pone.0001774.t002

M. Bourraindeloup, C. Adamy, G. Candiani, M. Cailleret, and M. Bourin, N-Acetylcysteine Treatment Normalizes Serum Tumor Necrosis Factor-?? Level and Hinders the Progression of Cardiac Injury in Hypertensive Rats, Circulation, vol.110, issue.14, pp.2003-2009, 2004.
DOI : 10.1161/01.CIR.0000143630.14515.7C

C. Adamy, P. Mulder, L. Khouzami, N. Andrieu-abadie, and N. Defer, Neutral sphingomyelinase inhibition participates to the benefits of N-acetylcysteine treatment in post-myocardial infarction failing heart rats, Journal of Molecular and Cellular Cardiology, vol.43, issue.3, pp.344-353, 2007.
DOI : 10.1016/j.yjmcc.2007.06.010
URL : https://hal.archives-ouvertes.fr/inserm-00158065

D. Yucel, S. Aydogdu, S. Cehreli, G. Saydam, and H. Canatan, Increased oxidative stress in dilated cardiomyopathic heart failure, Clin Chem, vol.44, pp.148-154, 1998.

J. Haddad and H. Harb, l-??-Glutamyl-l-cysteinyl-glycine (glutathione; GSH) and GSH-related enzymes in the regulation of pro- and anti-inflammatory cytokines: a signaling transcriptional scenario for redox(y) immunologic sensor(s)?, Molecular Immunology, vol.42, issue.9, pp.987-1014, 2005.
DOI : 10.1016/j.molimm.2004.09.029

R. Franco, O. Schoneveld, A. Pappa, and M. Panayiotidis, The central role of glutathione in the pathophysiology of human diseases, Archives of Physiology and Biochemistry, vol.134, issue.4-5, pp.234-258, 2007.
DOI : 10.1182/blood-2003-12-4299

N. Schiller, P. Shah, M. Crawford, A. Demaria, and R. Devereux, Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography, Journal of the American Society of Echocardiography, vol.2, issue.5, pp.358-367, 1989.
DOI : 10.1016/S0894-7317(89)80014-8

K. Dickstein, A. Cohen-solal, G. Filippatos, J. Mcmurray, and P. Ponikowski, ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008???, European Journal of Heart Failure, vol.9, issue.4, pp.933-989, 2008.
DOI : 10.1016/j.ejheart.2008.08.005

V. Fuster, L. Ryden, D. Cannom, H. Crijns, and A. Curtis, guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation), Eur Heart J, vol.27, pp.1979-2030, 2006.

F. Tietze, Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues, Analytical Biochemistry, vol.27, issue.3, pp.502-522, 1969.
DOI : 10.1016/0003-2697(69)90064-5

I. Rahman, A. Kode, and S. Biswas, Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method, Nature Protocols, vol.63, issue.6, pp.3159-3165, 2006.
DOI : 10.1038/nprot.2006.378

C. Carnes, P. Janssen, M. Ruehr, H. Nakayama, and T. Nakayama, Atrial Glutathione Content, Calcium Current, and Contractility, Journal of Biological Chemistry, vol.282, issue.38, pp.28063-28073, 2007.
DOI : 10.1074/jbc.M704893200

Z. Mallat, I. Philip, M. Lebret, D. Chatel, and J. Maclouf, Elevated Levels of 8-iso-Prostaglandin F2?? in Pericardial Fluid of Patients With Heart Failure : A Potential Role for In Vivo Oxidant Stress in Ventricular Dilatation and Progression to Heart Failure, Circulation, vol.97, issue.16, pp.1536-1539, 1998.
DOI : 10.1161/01.CIR.97.16.1536

F. Giordano, Oxygen, oxidative stress, hypoxia, and heart failure, Journal of Clinical Investigation, vol.115, issue.3, pp.500-508, 2005.
DOI : 10.1172/JCI200524408

M. Hill and P. Singal, Right and Left Myocardial Antioxidant Responses During Heart Failure Subsequent to Myocardial Infarction, Circulation, vol.96, issue.7, pp.2414-2420, 1997.
DOI : 10.1161/01.CIR.96.7.2414

C. Lang, B. Mills, W. Mastropaolo, and M. Liu, Blood glutathione decreases in chronic diseases, Journal of Laboratory and Clinical Medicine, vol.135, issue.5, pp.402-405, 2000.
DOI : 10.1067/mlc.2000.105977

G. Wu, Y. Fang, S. Yang, J. Lupton, and N. Turner, Glutathione metabolism and its implications for health, J Nutr, vol.134, pp.489-492, 2004.

A. Amadou, A. Nawrocki, M. Best-belpomme, C. Pavoine, and F. Pecker, Arachidonic acid mediates dual effect of TNF-alpha on Ca2+ transients and contraction of adult rat cardiomyocytes, AJP: Cell Physiology, vol.282, issue.6, pp.1339-1347, 2002.
DOI : 10.1152/ajpcell.00471.2001

M. Cailleret, A. Amadou, N. Andrieu-abadie, A. Nawrocki, and C. Adamy, N-Acetylcysteine Prevents the Deleterious Effect of Tumor Necrosis Factor-?? on Calcium Transients and Contraction in Adult Rat Cardiomyocytes, Circulation, vol.109, issue.3, pp.406-411, 2004.
DOI : 10.1161/01.CIR.0000109499.00587.FF

N. Defer, A. Azroyan, F. Pecker, and C. Pavoine, TNFR1 and TNFR2 Signaling Interplay in Cardiac Myocytes, Journal of Biological Chemistry, vol.282, issue.49, pp.35564-35573, 2007.
DOI : 10.1074/jbc.M704003200

M. Ozaydin, O. Peker, D. Erdogan, S. Kapan, and Y. Turker, N-acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study, European Heart Journal, vol.29, issue.5, pp.625-631, 2008.
DOI : 10.1093/eurheartj/ehn011